147 related articles for article (PubMed ID: 14501770)
1. Androgen receptors in prostate cancer.
Culig Z; Klocker H; Bartsch G; Steiner H; Hobisch A
J Urol; 2003 Oct; 170(4 Pt 1):1363-9. PubMed ID: 14501770
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of androgen receptor coactivators in prostate cancer.
Culig Z; Comuzzi B; Steiner H; Bartsch G; Hobisch A
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):265-71. PubMed ID: 15663989
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor--an update of mechanisms of action in prostate cancer.
Culig Z; Hobisch A; Bartsch G; Klocker H
Urol Res; 2000 Aug; 28(4):211-9. PubMed ID: 11011957
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor signaling in prostate cancer.
Culig Z; Santer FR
Cancer Metastasis Rev; 2014 Sep; 33(2-3):413-27. PubMed ID: 24384911
[TBL] [Abstract][Full Text] [Related]
5. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.
Heemers HV; Regan KM; Dehm SM; Tindall DJ
Cancer Res; 2007 Nov; 67(21):10592-9. PubMed ID: 17975004
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor in prostate cancer.
Heinlein CA; Chang C
Endocr Rev; 2004 Apr; 25(2):276-308. PubMed ID: 15082523
[TBL] [Abstract][Full Text] [Related]
7. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells.
Masiello D; Chen SY; Xu Y; Verhoeven MC; Choi E; Hollenberg AN; Balk SP
Mol Endocrinol; 2004 Oct; 18(10):2388-401. PubMed ID: 15256534
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptors in prostate cancer.
Culig Z; Klocker H; Bartsch G; Hobisch A
Endocr Relat Cancer; 2002 Sep; 9(3):155-70. PubMed ID: 12237244
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.
Taplin ME; Balk SP
J Cell Biochem; 2004 Feb; 91(3):483-90. PubMed ID: 14755679
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor mutations in carcinoma of the prostate: significance for endocrine therapy.
Culig Z; Klocker H; Bartsch G; Hobisch A
Am J Pharmacogenomics; 2001; 1(4):241-9. PubMed ID: 12083956
[TBL] [Abstract][Full Text] [Related]
12. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells.
Gao J; Isaacs JT
Cancer Res; 1998 Aug; 58(15):3299-306. PubMed ID: 9699659
[TBL] [Abstract][Full Text] [Related]
13. Androgen-receptor gene structure and function in prostate cancer.
Hakimi JM; Rondinelli RH; Schoenberg MP; Barrack ER
World J Urol; 1996; 14(5):329-37. PubMed ID: 8912473
[TBL] [Abstract][Full Text] [Related]
14. Androgen axis in prostate cancer.
Culig Z; Bartsch G
J Cell Biochem; 2006 Oct; 99(2):373-81. PubMed ID: 16598769
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.
Mashima T; Okabe S; Seimiya H
Mol Pharmacol; 2010 Nov; 78(5):846-54. PubMed ID: 20709811
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.
Taplin ME; Rajeshkumar B; Halabi S; Werner CP; Woda BA; Picus J; Stadler W; Hayes DF; Kantoff PW; Vogelzang NJ; Small EJ;
J Clin Oncol; 2003 Jul; 21(14):2673-8. PubMed ID: 12860943
[TBL] [Abstract][Full Text] [Related]
17. Androgen receptor corepressors and prostate cancer.
Burd CJ; Morey LM; Knudsen KE
Endocr Relat Cancer; 2006 Dec; 13(4):979-94. PubMed ID: 17158750
[TBL] [Abstract][Full Text] [Related]
18. Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status.
Wetherill YB; Fisher NL; Staubach A; Danielsen M; de Vere White RW; Knudsen KE
Cancer Res; 2005 Jan; 65(1):54-65. PubMed ID: 15665279
[TBL] [Abstract][Full Text] [Related]
19. Pleiotropic functional properties of androgen receptor mutants in prostate cancer.
Bergerat JP; Céraline J
Hum Mutat; 2009 Feb; 30(2):145-57. PubMed ID: 18800375
[TBL] [Abstract][Full Text] [Related]
20. Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer.
Febbo PG; Lowenberg M; Thorner AR; Brown M; Loda M; Golub TR
J Urol; 2005 May; 173(5):1772-7. PubMed ID: 15821585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
